MYCOPHENOLATE MOFETIL ORION 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil orion 500 mg tabletti, kalvopäällysteinen

orion corporation - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo

MYCOPHENOLIC ACID RATIOPHARM 180 mg enterotabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolic acid ratiopharm 180 mg enterotabletti

ratiopharm gmbh - natrii mycophenolas - enterotabletti - 180 mg - mykofenolihappo

MYCOPHENOLIC ACID RATIOPHARM 360 mg enterotabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolic acid ratiopharm 360 mg enterotabletti

ratiopharm gmbh - natrii mycophenolas - enterotabletti - 360 mg - mykofenolihappo

MS-H Vaccine Euroopan unioni - suomi - EMA (European Medicines Agency)

ms-h vaccine

pharmsure veterinary products europe ltd - mycoplasma synoviae -kanta ms-h - immunologisia valmisteita varten aves, eläviä bakteereja sisältäviä rokotteita - kana - aktiivinen immunisointi tulevaisuuden broileri kasvattaja kanoja, tulevaisuuden kerros kasvattaja kanoja ja tulevaisuuden kerros kanoja vähentää ilman sac vaurioita ja vähentää munien kanssa epänormaalia kuoren muodostumisen aiheuttama mycoplasma synoviae.

Mhyosphere PCV ID Euroopan unioni - suomi - EMA (European Medicines Agency)

mhyosphere pcv id

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - siat - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

MYCOPHENOLATE MOFETIL RATIOPHARM 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil ratiopharm 500 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo

MYCOPHENOLATE MOFETIL STADA 250 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil stada 250 mg kapseli, kova

stada arzneimittel ag - mofetilis mycophenolas - kapseli, kova - 250 mg - mykofenolihappo

MYCOPHENOLATE MOFETIL STADA 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil stada 500 mg tabletti, kalvopäällysteinen

stada arzneimittel ag - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo

MYCOPHENOLATE MOFETIL ORIFARM 250 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil orifarm 250 mg tabletti, kalvopäällysteinen

orifarm generics a/s orifarm generics a/s - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 250 mg - mykofenolihappo

MYCOPHENOLATE MOFETIL ORIFARM 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

mycophenolate mofetil orifarm 500 mg tabletti, kalvopäällysteinen

orifarm generics a/s orifarm generics a/s - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo